ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer
Condition(s):Endometrial Cancer; MetastasisLast Updated:September 8, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Endometrial Cancer; MetastasisLast Updated:September 8, 2023Recruiting
Condition(s):Cervical Carcinoma; Endometrial CarcinomaLast Updated:December 21, 2023Recruiting
Condition(s):Advanced Endometrial Cancer; Sarcoma of UterusLast Updated:July 24, 2023Recruiting
Condition(s):Endometrial CancerLast Updated:January 14, 2020Not yet recruiting
Condition(s):Endometrium CancerLast Updated:December 13, 2023Recruiting
Condition(s):Lynch Syndrome; Recurrent Uterine Corpus Carcinoma; Stage I Uterine Corpus Cancer; Stage II Uterine Corpus Cancer; Stage III Uterine Corpus Cancer; Stage IV Uterine Corpus CancerLast Updated:May 29, 2015Not yet recruiting
Condition(s):Endometrial CancerLast Updated:March 4, 2024Recruiting
Condition(s):Endometrial Cancer RecurrentLast Updated:June 8, 2022Recruiting
Condition(s):Endometrial CancerLast Updated:December 22, 2023Recruiting
Condition(s):Endometrial Carcinoma; Tumor Molecular Features Screening ModelLast Updated:June 8, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.